Home - Products - Apoptosis - Apoptosis - 9-dihydro-13-acetylbaccatin III

9-dihydro-13-acetylbaccatin III

CAS No. 142203-65-4

9-dihydro-13-acetylbaccatin III( 13-Acetyl-9-dihydrobaccatin III | 9-DHAB III )

Catalog No. M19922 CAS No. 142203-65-4

9-Dihydro-13-acetylbaccatin III is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
5MG 33 In Stock
10MG 55 In Stock
25MG 111 In Stock
50MG 161 In Stock
100MG 239 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    9-dihydro-13-acetylbaccatin III
  • Note
    Research use only, not for human use.
  • Brief Description
    9-Dihydro-13-acetylbaccatin III is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR.
  • Description
    9-Dihydro-13-acetylbaccatin III is an apoptosis inducer. It shows cytotoxicity against the MCF7 cell line and drug-resistant cell line MCF7-ADR.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    13-Acetyl-9-dihydrobaccatin III | 9-DHAB III
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    142203-65-4
  • Formula Weight
    630.68
  • Molecular Formula
    C33H42O12
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM;Ethanol: Soluble
  • SMILES
    CC(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)[C@@H](O)[C@H](OC(C)=O)C(=C1C)C2(C)C)OC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nikolakakis A et al. Semi-synthesis of an O-glycosylated docetaxel analogue. Bioorg Med Chem. 2003 Apr 3;11(7):1551-6.
molnova catalog
related products
  • Pivanex

    Pivanex is an orally active HDAC inhibitor and an antimetastatic and antiangiogenic agent. Pivanex downregulates the Bcr-Abl protein and enhances apoptosis.

  • icFSP1

    icFSP1 is a mitochondria-associated apoptosis-inducing factor regulator with antitumor activity for the study and treatment of tumor diseases.

  • CWI1-2 HCL

    CWI1-2 HCL is an effective IGF2BP2 inhibitor, which can induce apoptosis and differentiation by binding IGF2BP2 and inhibiting its interaction with M6A-modified target transcription, and has therapeutic effects on leukemia.